alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityResearch on Law Enforcement Responses to Opioid Overdoses (Funding Opportunity)

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -           Report: Diagnoses and Prevalence of HIV Infection Among Hispanics or Latinos      

# Report: Diagnoses and Prevalence of HIV Infection Among Hispanics or Latinos

CDC researchers analyzed data from the National HIV Surveillance System to determine the numbers and rates of diagnosis of HIV infection among Hispanics or Latinos 13-years-old or older between 2008 and 2013. Results show that Hispanics or Latinos accounted for 20% of HIV diagnoses, and the rate of diagnoses among males was six times the rate among females. 

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6439a2.htm?s_cid=mm6439a2_w&utm_source=youth.gov&utm_medium=federal-links&utm_campaign=reports-and-resources
#### 752.7015 Use of pouch facilities.

For use in all USAID non-commercial contracts exceeding the simplified acquisition threshold and involving performance overseas.

# Use of Pouch Facilities (JUL 1997)

(a) Use of diplomatic pouch is controlled by the Department of State. The Department of State has authorized the use of pouch facilities for USAID contractors and their employees as a general policy, as detailed in paragraphs (a)(1) through (a)(7) of this clause; however, the final decision regarding use of pouch facilities rests with the Embassy or USAID Mission. In consideration of the use of pouch facilities as hereinafter stated, the Contractor and its employees agree to indemnify and hold harmless the Department of State and USAID against loss or damage occurring in pouch transmission.

(1) Contractors and their employees are authorized use of the pouch for transmission and receipt of up to a maximum of 0.9 kilogram/2 pounds per shipment of correspondence and documents needed in the administration of foreign assistance programs.

(2) U.S. citizen employees of U.S. contractors are authorized use of the pouch for personal mail up to a maximum of 0.5 kilogram/one pound per shipment (but see paragraph (a)(3) of this section).

(3) Merchandise, parcels, magazines, or newspapers are not considered to be personal mail for purposes of this clause, and are not authorized to be sent or received by pouch.

(4) Official mail as authorized by paragraph (a)(1) of this clause should be addressed as follows: Individual or Organization name, followed by the symbol “C”, city Name of Post, U.S. Agency for International Development, Washington, DC 20523-0001.

(5) Personal mail pursuant to paragraph (a)(2) of this clause should be sent to the address specified in paragraph (a)(4) of this clause, but without the name of the organization.

(6) Mail sent via the diplomatic pouch may not be in violation of U.S. Postal laws and may not contain material ineligible for pouch transmission.

(7) USAID contractor personnel are not authorized use of military postal facilities (APO/FPO). This is an Adjutant General's decision based on existing laws and regulations governing military postal facilities and is being enforced worldwide. Posts having access to APO/FPO facilities and using such for diplomatic pouch dispatch, may, however, accept official mail from Contractors and letter mail from their employees for the pouch, provided of course, adequate postage is affixed.

(b) The Contractor shall be responsible for advising its employees of this authorization and these guidelines and limitations on use of pouch facilities.

(c) Specific additional guidance on use of pouch facilities in accordance with this clause is available from the Post Communication Center at the Embassy or USAID Mission.

(End of clause)

[49 FR 13259, Apr. 3, 1984, as amended at 56 FR 2699, Jan. 24, 1991; 57 FR 5237, Feb. 13, 1992; 62 FR 40471, July 29, 1997; 62 FR 45334, Aug. 27, 1997; 79 FR 75002, Dec. 16, 2014; 89 FR 4209, Jan. 23, 2024]
#### § 1.119 Disclosure of record to person other than the individual to whom it pertains.

No agency shall disclose any record which is contained in a system of records it maintains, by any means of communication to any person, or to another agency outside USDA, except pursuant to a written request by, or with the prior written consent of, the individual to whom the record pertains, unless the disclosure is authorized by one or more provisions of 5 U.S.C. 552a(b).
II 

Calendar No. 455 

118TH CONGRESS 

2D SESSION H. R. 1060 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 1, 2024 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AUGUST 1, 2024 

Reported by Mr. PETERS, without amendment 

AN ACT 

To designate the facility of the United States Postal Service 

located at 1663 East Date Place in San Bernardino, 

California, as the ‘‘Dr. Margaret B. Hill Post Office 

Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DR. MARGARET B. HILL POST OFFICE BUILD4 ING. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 1663 East Date Place in San 

7 Bernardino, California, shall be known and designated as 

8 the ‘‘Dr. Margaret B. Hill Post Office Building’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 1060 RS

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Dr. Margaret B. Hill 

5 Post Office Building’’. 


ssavage on LAPJG3WLY3PROD with BILLS

ssavage on LAPJG3WLY3PROD with BILLS
Calendar No. 455 

118TH CONGRESS 

2D SESSION H. R. 1060 

AN ACT 

To designate the facility of the United States Postgaret B. Hill Post Office Building’’. San Bernardino, California, as the ‘‘Dr. Mar- al Service located at 1663 East Date Place in 

AUGUST 1, 2024 

Reported without amendment 


ssavage on LAPJG3WLY3PROD with BILLS
**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTINGFIRM**

Weconsent to the incorporation by reference in the Registration Statements (FormsS-3 Nos. 333-66269, 333-87038, 333-104954 and 333-110158and S-8 Nos. 333-59164, 333-19465, 333-06771, 333-06765,333-88544 and 333-116662) of Cypress Bioscience, Inc. of ourreports dated February 25, 2005 with respect to: (1) the financialstatements of Cypress Bioscience, Inc., and (2) management’sassessment of the effectiveness of internal control over financial reporting,and the effectiveness of internal control over financial reporting of CypressBioscience, Inc., included in this Annual Report (Form 10-K)for the year ended December 31, 2004.
|                       | /s/ Ernst & Young LLP |
|-----------------------|--------------------------------|
| San Diego, California |                           |
| March 11, 2005   |                           |

 

----
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -           YouthLead      

# YouthLead

This website is a virtual platform for young people, between the ages of 15 and 35, who want to make positive change in their communities. It provides opportunities to connect with like-minded networks of young people, mentors, as well as resources and events. 

https://www.youthlead.org/
903.970 Remedies. ( a ) Contractors found to have retaliated against an employee in reprisal for such disclosure, participation or refusal are required to provide relief in accordance with decisions issued under 10 CFR part 708.
( b ) 10 CFR part 708 provides that for the purposes of the Contract Disputes Act (41 U.S.C. 605 and 606), a final decision issued pursuant to 10 CFR part 708 shall not be considered to be a claim by the Government against a contractor or a decision by the contracting officer subject to appeal. However, a contractor's disagreement and refusal to comply with a final decision could result in a contracting officer's decision to disallow certain costs or to terminate the contract for default. In such case, the contractor could file a claim under the Disputes clause of the contract regarding the disallowance of cost or the termination of the contract.
#### 629.202 General exemptions.
Exhibit



EXHIBIT 10.15



[LETTERHEAD OF SEARS HOLDINGS CORPORATION]


 
October 13, 2016
Robert A. Riecker
Dear Rob,
In recognition of your past and future contributions to Sears Holdings Corporation (“SHC”), subject to the approval of the Compensation Committee (“Compensation Committee”) of Sears Holdings Corporation’s Board of Directors, we are pleased to provide you, effective October 14, 2016, with the following changes to your position and compensation:
		
	•
	You will now serve Sears Holdings Corporation in the position of Controller & Head of Capital Market Activities; and


		
	•
	Subject to all terms and conditions of the Sears Holdings Corporation Annual Incentive Plan (“AIP”), including but not limited to the requirement you remain actively employed by SHC through the payment date of the applicable fiscal year’s AIP, your minimum annual incentive bonus for the 2017 and 2018 fiscal years shall be $262,500.


		
	•
	Subject to all terms and conditions of the Executive Severance Agreement executed by you on October 3, 2011 (the “ESA”):


		
	o
	Your severance period is increased to twelve (12) months. This means that if Severance Benefits (as defined in the ESA) become due and owing, (a) the amount of cash severance paid to you will equal to twelve (12) months of pay at your annual base salary rate as of your Date of Termination (as defined in the ESA), and (b) benefits continuation, i.e., remaining in certain health and welfare plans at active associate rates, will be available for twelve (12) months from your Date of Termination (subject to the terms and conditions and continued availability of such plans and programs); and


		
	o
	The period during which the non-compete will apply is increased from six (6) to twelve (12) months.


All terms and conditions of your employment not specifically addressed in this letter remain in full force and effect, including but not limited to each of the following:
		
	•
	Offer Letter and Executive Severance Agreement each executed by you on October 3, 2011,















		
	•
	Internal Action letter dated June 29, 2014, and executed by you on February 6, 2014,


		
	•
	Special Retention Award Agreement dated August 27, 2015, and executed by you on September 1, 2015, and


		
	•
	Internal Action letter dated August 15, 2016, and executed by you on August 17, 2016.


To acknowledge and accept these changes, please sign and date below.
	
				
	 
	 
	Very truly yours,
	 

	 
	 
	 
	 

	 
	 
	Tiffany Morris
	 

	 
	 
	Vice President, Human Resources
	 

	 
	 
	 
	 

	Accepted:
	 
	 
	 

	/s/ Robert A. Riecker
	 
	10/13/2016
	 

	Robert A. Riecker
	 
	Date
	 










2
<PAGE>
Exhibit 99.2


              Certification Pursuant to Section 1350 of Chapter 63
                     of Title 18 of the United States Code


         I, Bruce A. Klein, the chief financial officer of CLARCOR Inc.,
certify that (i) the Form 10-Q Quarterly Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and (ii) the information contained in the Form 10-Q Quarterly Report fairly
presents, in all material respects, the financial condition and results of
operations of CLARCOR Inc.


                                                       /s/ Bruce A. Klein
                                                   ----------------------------
                                                          Bruce A. Klein
                                                   Vice President - Finance and
                                                      Chief Financial Officer


                                      iii
#### 47.103 Transportation Payment and Audit Regulation.
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityResearch on Law Enforcement Responses to Opioid Overdoses (Funding Opportunity)

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -           Use of Selected Clinical Preventive Services to Improve the Health of Infants, Children, and Adolescents — United States, 1999-2011      

# Use of Selected Clinical Preventive Services to Improve the Health of Infants, Children, and Adolescents — United States, 1999-2011

This report from the CDC finds that infants, children, and adolescents in the United States did not receive key clinical preventive services that have the potential to improve their health. The report also points to disparities in access and use of these services by demographics, geography, and health care coverage status.

http://www.cdc.gov/childpreventiveservices/index.html?utm_source=FindYouthInfo.gov&utm_medium=Federal%20Links&utm_campaign=Reports-and-Resources
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000020639
<NAME>                        AmBase Corporation
<MULTIPLIER>                                   1,000


<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-1-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         1,334
<SECURITIES>                                   50,373
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 53,444
<CURRENT-LIABILITIES>                          0
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       463
<OTHER-SE>                                     (23,571)
<TOTAL-LIABILITY-AND-EQUITY>                   53,444
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               3,343
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                6,273
<INCOME-TAX>                                   110
<INCOME-CONTINUING>                            6,163
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   0
<EPS-BASIC>                                    0.13
<EPS-DILUTED>                                  0.13



</TABLE>
Exhibit 4.2


 



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM







We have issued our report dated June 2, 2017, with respect to the financial statement of Alaia Market Linked Trust Series 1-2, comprising the Alaia Defined Outcome Solution, contained in Amendment No. 1 to the Registration Statement on Form S-6 (File No. 333-215809) and related Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Independent Registered Public Accounting Firm”.

















/s/ GRANT THORNTON LLP

















Chicago, Illinois


June 2, 2017
Exhibit 32.1
                                                            ------------

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with  the  quarterly  report  of  AmBase  Corporation  (the
"Company")  on Form 10-Q for the period  ending  June 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Richard
A.  Bianco,  Chief  Executive  Officer of the Company,  certify,  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that to my knowledge:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.


Date: August 11, 2006                   /s/ Richard A. Bianco
                                        ---------------------
                                        Richard A. Bianco
                                        Chairman, President and
                                        Chief Executive Officer
                                        AmBase Corporation
#### 647.305-71 Shipping instructions.

The contracting officer shall insert the clause at 652.247-71, Shipping Instructions, in solicitations and contracts with a source in the United States if overseas shipment of supplies is required.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                           8,320
<SECURITIES>                                         0
<RECEIVABLES>                                   26,509
<ALLOWANCES>                                         0
<INVENTORY>                                     92,045
<CURRENT-ASSETS>                               130,445
<PP&E>                                          68,140
<DEPRECIATION>                                  39,073
<TOTAL-ASSETS>                                 172,021
<CURRENT-LIABILITIES>                           30,161
<BONDS>                                         66,083
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,155
<OTHER-SE>                                      73,622
<TOTAL-LIABILITY-AND-EQUITY>                   172,021
<SALES>                                        158,774
<TOTAL-REVENUES>                               158,774
<CGS>                                          117,406
<TOTAL-COSTS>                                  147,251
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,570
<INCOME-PRETAX>                                  8,794
<INCOME-TAX>                                     3,242
<INCOME-CONTINUING>                              5,552
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,552
<EPS-PRIMARY>                                     0.26
<EPS-DILUTED>                                     0.26
        

</TABLE>
#### In re E. C. BELL MFG. CO.

(Supreme Court, Appellate Division, First Department.

June 20, 1906.)

In the matter of the E. C. Bell Manufacturing Company.

No opinion. Order affirmed, with $10 costs and disbursements. Motion dismissed, without costs.